Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04605211 · ClinicalTrials.gov registry record · NA
A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
A NA study of Myeloproliferative Neoplasm and Chronic Myeloid Leukemia, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT04605211 is a NA study of Myeloproliferative Neoplasm and Chronic Myeloid Leukemia that has completed, run by University of California, San Francisco. The registered enrollment target is 47 participants, below the 84-participant average among 40 other Myeloproliferative Neoplasm trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04605211, a NA study of Myeloproliferative Neoplasm and Chronic Myeloid Leukemia, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial looks at how well a distress reduction intervention, called "Being Present", works to improve the quality of life of patients with BCR-ABL-negative myeloproliferative neoplasms (MPNs) or chronic phase chronic myeloid leukemia (CP-CML) who are taking tyrosine kinase inhibitors (TKIs) and their caregivers. Mindfulness meditation is the practice of repeatedly bringing attention back to the immediate experience and may help people cope with various types of illness, stress, and worry. This may help patients and caregivers to gradually learn to disconnect from reacting to and dwelling on the past and future and instead fully experiencing the present moment.
Conditions Studied
Interventions
- BEHAVIORAL Online Mindfulness Meditation
- OTHER Internet-Based Webinars
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2020-09-18 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04605211
The ClinicalTrials.gov registry entry for NCT04605211 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 84-participant average among 40 other Myeloproliferative Neoplasm trials with a reported enrollment target (44% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Myeloproliferative Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Online Mindfulness Meditation is the first listed.
NCT04605211 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04605211 about?
NCT04605211 is a clinical study titled "A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors". This trial looks at how well a distress reduction intervention, called "Being Present", works to improve the quality of life of patients with BCR-ABL-negative myeloproliferative neoplasms (MPNs) or chronic phase chronic myeloid leukemia (CP-CML) who are taking tyrosine kinase inhibitors (TKIs) and t...
What is the current status of trial NCT04605211?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2020-09-18. Estimated completion is 2022-09-30.
What conditions does trial NCT04605211 study?
This clinical trial studies the following conditions: Myeloproliferative Neoplasm, Chronic Myeloid Leukemia, Chronic Phase Chronic Myelogenous Leukemia.
What interventions are being tested in trial NCT04605211?
The interventions under investigation include: Online Mindfulness Meditation (BEHAVIORAL), Internet-Based Webinars (OTHER).
Who is sponsoring clinical trial NCT04605211?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04605211 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myeloproliferative Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
RECRUITING · NA
-
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
RECRUITING · NA
-
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
ACTIVE NOT RECRUITING · NA
-
Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm
COMPLETED · NA
-
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.